213 related articles for article (PubMed ID: 1843713)
21. Mechanism of bronchodilator effect in chronic airflow limitation.
Jaeschke R; Guyatt GH; Singer J; Keller J; Newhouse MT
CMAJ; 1991 Jan; 144(1):35-9. PubMed ID: 1984814
[TBL] [Abstract][Full Text] [Related]
22. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
Chhabra SK; Bhatnagar S
Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
[TBL] [Abstract][Full Text] [Related]
23. The effect of maintenance theophylline therapy on lung work in severe chronic obstructive pulmonary disease while standing and walking.
Jenne JW; Siever JR; Druz WS; Solano JV; Cohen SM; Sharp JT
Am Rev Respir Dis; 1984 Oct; 130(4):600-5. PubMed ID: 6486559
[TBL] [Abstract][Full Text] [Related]
24. [Comparing the bronchodilating effects of ipratropium bromide and theophylline].
Dai L; Li X; Yang Y
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880
[TBL] [Abstract][Full Text] [Related]
25. [Euphylong in patients with chronic obstructive airway diseases].
Kublik A; von Wichert P
Pneumologie; 1991 Nov; 45 Suppl 4():858-62. PubMed ID: 1812480
[TBL] [Abstract][Full Text] [Related]
26. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E
Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466
[TBL] [Abstract][Full Text] [Related]
27. Double-blind comparison of tulobuterol and salbutamol in chronic obstructive pulmonary disease.
Germouty J
Clin Ther; 1986; 8(5):546-53. PubMed ID: 2876775
[TBL] [Abstract][Full Text] [Related]
28. Physiological and neuropsychological effects of theophylline in chronic obstructive pulmonary disease.
Newman D; Tamir J; Speedy L; Newman JP; Ben-Dov I
Isr J Med Sci; 1994 Nov; 30(11):811-6. PubMed ID: 7982769
[TBL] [Abstract][Full Text] [Related]
29. [The influence of serum theophylline concentration on the bronchodilating effect of salbutamol inhalation for bronchial asthma].
Tsukioka K; Nakamata M; Kondo A; Hashimoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jul; 28(7):950-5. PubMed ID: 1977948
[TBL] [Abstract][Full Text] [Related]
30. [Response to the administration of corticosteroids in patients with chronic obstructive lung disease and asthma].
Barbas Filho JV; Barbas CS; de Carvalho CR; Godoy R; Vianna Edos S; Lorenzi Filho G
Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):159-62. PubMed ID: 1843711
[TBL] [Abstract][Full Text] [Related]
31. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM
Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction.
Taylor DR; Buick B; Kinney C; Lowry RC; McDevitt DG
Am Rev Respir Dis; 1985 May; 131(5):747-51. PubMed ID: 4003919
[TBL] [Abstract][Full Text] [Related]
33. The effects of inhaled albuterol and oral theophylline on gastroesophageal reflux in patients with gastroesophageal reflux disease and obstructive lung disease.
Ruzkowski CJ; Sanowski RA; Austin J; Rohwedder JJ; Waring JP
Arch Intern Med; 1992 Apr; 152(4):783-5. PubMed ID: 1558436
[TBL] [Abstract][Full Text] [Related]
34. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
Chrystyn H; Mulley BA; Peake MD
BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
[TBL] [Abstract][Full Text] [Related]
35. [Kombipek in the therapy of patients with broncho-obstructive lung diseases].
Chuchalin AG; Tsoĭ AN; Zaĭtseva TM; Titova EV; Medani SM; Smirnov MV; Kaziakhmedov EA
Ter Arkh; 1995; 67(6):26-9. PubMed ID: 7667774
[TBL] [Abstract][Full Text] [Related]
36. Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction.
Freitag A
Med J Aust; 1976 Apr; 1(14):478-9. PubMed ID: 933924
[TBL] [Abstract][Full Text] [Related]
37. Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease.
Bleecker ER; Britt EJ
Am J Med; 1991 Oct; 91(4A):24S-27S. PubMed ID: 1835291
[TBL] [Abstract][Full Text] [Related]
38. Relationship between serum theophylline levels and pulmonary function before and after inhaled beta-agonist in "stable" asthmatics.
Klein JJ; Lefkowitz MS; Spector SL; Cherniack RM
Am Rev Respir Dis; 1983 Apr; 127(4):413-6. PubMed ID: 6132573
[TBL] [Abstract][Full Text] [Related]
39. Use of serum theophylline level as a guide to optimum therapy in patients with chronic obstructive lung disease.
Ashutosh K; Bajaj R; Cho CD; Sangani G
J Clin Pharmacol; 1990 Apr; 30(4):324-9. PubMed ID: 2160479
[TBL] [Abstract][Full Text] [Related]
40. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life.
Guyatt GH; Townsend M; Pugsley SO; Keller JL; Short HD; Taylor DW; Newhouse MT
Am Rev Respir Dis; 1987 May; 135(5):1069-74. PubMed ID: 3579005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
